Sage Therapeutics (SAGE) SAGE-217 Ph3 Data 'Very Impressive' - BMO

Go back to Sage Therapeutics (SAGE) SAGE-217 Ph3 Data 'Very Impressive' - BMO

Form 8-K Sage Therapeutics, Inc. For: Jan 07

January 7, 2019 7:31 AM EST

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

... More